Femiint health and Fertility Revenue and Competitors
Estimated Revenue & Valuation
- Femiint health and Fertility's estimated annual revenue is currently $2.1M per year.
- Femiint health and Fertility's estimated revenue per employee is $94,500
Employee Data
- Femiint health and Fertility has 22 Employees.
- Femiint health and Fertility grew their employee count by -19% last year.
Femiint health and Fertility's People
Name | Title | Email/Phone |
---|
Femiint health and Fertility Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $80.3M | 476 | 27% | N/A | N/A |
#2 | $41.6M | 280 | -4% | N/A | N/A |
#3 | $35.2M | 237 | 30% | N/A | N/A |
#4 | $75.1M | 445 | 5% | N/A | N/A |
#5 | $34.3M | 231 | 7% | N/A | N/A |
#6 | $89.8M | 524 | 17% | $13.2M | N/A |
#7 | $133.1M | 704 | 7% | N/A | N/A |
#8 | $142.7M | 755 | 19% | N/A | N/A |
#9 | $44.3M | 298 | 5% | N/A | N/A |
#10 | $170.9M | 904 | 7% | N/A | N/A |
What Is Femiint health and Fertility?
Femiint Health sets a whole new paradigm in personalized women's healthcare with advanced expertise in the field of fertility & IVF treatments. Our core services include maternity, gynecology, advanced laparoscopic and minimally invasive gynecological surgeries, state of the art center for Reproductive medicine and IVF, birthing center, Pediatric department including NICU & PICU. We also focus on dermatology, Cosmetology, and hair transplant services with a team of expert doctors and high-end treatment facilities. Femiint Fertility has been ranked 3rd at the 'All India Fertility & IVF Ranking Survey 2019' by Times Health Survey."
keywords:N/AN/A
Total Funding
22
Number of Employees
$2.1M
Revenue (est)
-19%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.9M | 22 | N/A | N/A |
#2 | $1.1M | 22 | N/A | N/A |
#3 | $1.1M | 22 | N/A | N/A |
#4 | $1.1M | 22 | N/A | N/A |
#5 | N/A | 22 | -4% | N/A |